Extended-spectrum beta-lactamases (ESBLs) have been increasingly reported in Europe
since their first description in 1983. During the 1990s, they were described mainly as …

Extended‐spectrum β‐lactamases (ESBLs) represent a major threat among resistant
bacterial isolates. The first types described were derivatives of the TEM‐1, TEM‐2 and SHV …

During the last decade, the efforts to combat multidrugresistant (MDR) microorganisms
mainly focused on gram-positive bacteria, namely, methicillin-resistant Staphylococcus …

Community-acquired urinary tract infection (CA-UTI) is the most common infection caused by
extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, but the clinical …

Abstract Treatment of community urinary tract infections (UTIs) caused by extended-
spectrum β lactamase (ESBL)-producing Escherichia coli (E. coli) is more expensive than …

The ongoing global spread and increased prevalence of CTX-M-type extended-spectrum β-
lactamases in Enterobacteriaceae is of great concern. The successful distribution of CTX-M …

The genetic characteristics and molecular epidemiology of extended-spectrum β-lactamases
(ESBLs) among Escherichia coli isolates were investigated at a general hospital and its …

The rapid emergence of multiresistant microbial pathogens, dubbed superbugs, is a serious
threat to human health. Extended spectrum beta lactamase (ESBL)-producing Escherichia …

Antimicrobial resistance (AMR) is a serious public health threat in both developed and
developing countries. Many developing countries, including Rwanda, lack adequate …

Background The class A carbapenemase KPC has disseminated rapidly worldwide,
challenging the treatment of Gram-negative infections. This report describes the first KPC …